Injection Site Reactions from an Integrated Analysis of Phase 2 and Phase 3 Clinical Trials of Lebrikizumab Treatment in Moderate-To-Severe Atopic Dermatitis

AuthID
 P-00Y-TGA
11
Author(s)
Gooderham, M
·
Shi, VY
·
Wollenberg, A
·
Torres, T
·
Gil, EG
·
Natalie, CR
·
Atwater, AR
·
Zhao, FY
·
Blauvelt, A
Document Type
Abstract
Year published
2023
Published
in BRITISH JOURNAL OF DERMATOLOGY, ISSN: 0007-0963
Volume: 188
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:001010423100015
Source Identifiers
ISSN: 0007-0963
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service